<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100757'>Pancreatoblastoma</z:hpo> (PB), or infantile pancreatic <z:mp ids='MP_0002038'>carcinoma</z:mp>, is an extremely rare <z:mp ids='MP_0009153'>pancreatic tumor</z:mp> in childhood, comprising 0.5% of pancreatic non-<z:chebi fb="32" ids="24621">endocrine</z:chebi> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although PB mainly presents during childhood but can also occur in adults </plain></SENT>
<SENT sid="2" pm="."><plain>PB tend to be less aggressive in infants and children compared to adults </plain></SENT>
<SENT sid="3" pm="."><plain>Children with PB usually present late with upper <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> and many have a palpable mass in the epigastrium </plain></SENT>
<SENT sid="4" pm="."><plain>Mechanical obstruction of the upper duodenum and gastric outlet by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> in the head of the pancreas may be associated with <z:hpo ids='HP_0002013'>vomiting</z:hpo>, <z:hpo ids='HP_0000952'>jaundice</z:hpo> and <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Histologically, PB is characterized with distinct acinar and squamoid cell differentiation </plain></SENT>
<SENT sid="6" pm="."><plain>PB has been associated with alterations in the Wnt signaling pathway and chromosome 11p loss of heterozygosity (LOH), <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The majority of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> arise in the head of the pancreas </plain></SENT>
<SENT sid="8" pm="."><plain>Alpha-fetoprotein may be elevated in up to 68% of patients with PB </plain></SENT>
<SENT sid="9" pm="."><plain>Ultrasound and CT scan may be useful but preoperative diagnosis is often quite difficult </plain></SENT>
<SENT sid="10" pm="."><plain>The treatment of choice is complete resection, that may often be curative </plain></SENT>
<SENT sid="11" pm="."><plain>The role of adjuvant chemotherapy or radiotherapy is still under discussion due to small number of patients treated as yet </plain></SENT>
<SENT sid="12" pm="."><plain>Chemotherapy regimens consisting of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="4911">etoposide</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>, and <z:chebi fb="2" ids="27899">cisplatin</z:chebi> have been used in neoadjuvant setting with anecdotal benefit </plain></SENT>
<SENT sid="13" pm="."><plain>Prognosis of this rare <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is good, when resected completely </plain></SENT>
<SENT sid="14" pm="."><plain>Prognosis is poorer, when there is <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> or when it is inoperable </plain></SENT>
<SENT sid="15" pm="."><plain>On the whole, PB is regarded to be a curable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>; hence the clinical diagnosis should be made early </plain></SENT>
<SENT sid="16" pm="."><plain>Awareness of this rare <z:e sem="disease" ids="C0030297" disease_type="Neoplastic Process" abbrv="">tumor of pancreas</z:e> is essential for early detection and proper management </plain></SENT>
<SENT sid="17" pm="."><plain>The author review the clinical presentation, etiology, diagnosis, treatment and prognosis of PB in this presentation </plain></SENT>
</text></document>